SCHEMBL675156

SCHEMBL675156

CCOS(=O)(=O)Nc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 2/20 0.52
CA1 P00915 2/20 0.47
CA2 P00918 2/20 0.47
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
MAPT P10636 1/20 0.46
IL1RN P18510 1/20 0.45
ERAP1 Q9NZ08 1/20 0.45
NPSR1 Q6W5P4 1/20 0.44
CA12 O43570 2/20 0.43
CA9 Q16790 2/20 0.43
AR P10275 2/20 0.42
ALDH1A1 P00352 1/20 0.42
PKM P14618 1/20 0.42
NR3C2 P08235 2/20 0.42
HPGD P15428 2/20 0.42
LMNA P02545 1/20 0.42
PGR P06401 1/20 0.42
PTGS2 P35354 1/20 0.41
GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27464511 0.82 KEAP1 (0.46) KEAP1CA1CA2KMT2AMEN1
SCHEMBL28876271 0.79 KEAP1 (0.47) KEAP1CA1CA2KMT2AMEN1
SCHEMBL27509690 0.79 LMNA (0.58) KMT2AMEN1ALDH1A1LMNAGAA
SCHEMBL9136815 0.79 NPC1 (0.49) CA1CA2CA12CA9HPGD
SCHEMBL28657038 0.78 CA1 (0.55) KEAP1CA1CA2KMT2AMEN1
SCHEMBL11868146 0.77 KEAP1 (0.47) KEAP1CA1CA2KMT2AMEN1
SCHEMBL30797878 0.77 CA2 (0.44) KEAP1CA1CA2KMT2AMEN1
SCHEMBL675949 0.77 KEAP1 (0.58) KEAP1CA1CA2KMT2AMEN1
SCHEMBL2016598 0.76 KEAP1 (0.56) KEAP1CA1CA2KMT2AMEN1
SCHEMBL5130306 0.76 CA2 (0.42) KEAP1CA1CA2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11254702-B2 Thionyl tetrafluoride modified compounds and uses THE SCRIPPS RESEARCH INSTITUTE (US) 2022-02-22 US disclosed
EP-3548465-A1 THIONYL TETRAFLUORIDE MODIFIED COMPOUNDS AND USES The Scripps Research Institute (US) 2019-10-09 EP disclosed
US-20190284226-A1 THIONYL TETRAFLUORIDE MODIFIED COMPOUNDS AND USES THE SCRIPPS RESEARCH INSTITUTE 2019-09-19 US disclosed
CN-109925312-A For treating the composition, preparation and method of eye disease 爱尔皮奥治疗有限公司 2019-06-25 CN disclosed
CN-105307498-B Compositions, formulations and methods for treating ocular diseases 爱尔皮奥治疗有限公司 2019-04-16 CN disclosed
WO-2018102433-A1 THIONYL TETRAFLUORIDE MODIFIED COMPOUNDS AND USES THE SCRIPPS RESEARCH INSTITUTE (US) 2018-06-07 WO disclosed
US-7968009-B2 Electrically conductive nanocomposite particles having a polyalkyl acrylate core and a polyaniline coating UPPA-UNIVERSITE DE PAU ET DES PAYS DE L'ADOUR (FR) 2011-06-28 US disclosed
US-20090212263-A1 ELECTRICALLY CONDUCTIVE NANOCOMPOSITE PARTICLES HAVING A POLYALKYL ACRYLATE CORE AND A POLYANILINE COATING CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190284226-A1 THIONYL TETRAFLUORIDE MODIFIED COMPOUNDS AND USES SFXN3, TST, SIRT3 KEAP1 1520/4885CA1 3383/4885CA2 3513/4885
US-11254702-B2 Thionyl tetrafluoride modified compounds and uses SFXN3, TST, SIRT3 KEAP1 1520/4885CA1 3383/4885CA2 3513/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.